Analyst Ratings for Palvella Therapeutics (PVLA)
PVLA Rating Summary
PVLA Price Target Summary
- Highest: $267.00 (TD Cowen)
- Lowest: $90.00 (LifeSci Capital)
- Average: $206.56
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$206.56 (+53.7%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/7/2026 | Mizuho | Graig Suvannavejh | New Coverage | Outperform (N/A) |
205.00 (N/A) |
90.43 (134.39) |
48.61% | Details |
| 12/5/2025 | BTIG » Updated 12/15/2025 |
Jeff Mukherjee | New Coverage | Buy (N/A) |
192.00 (167.00) |
93.80 (134.39) |
43.27% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


